S'il est approuvé, l'obicetrapib, sous licence de NewAmsterdam Pharma, sera le premier inhibiteur de la CETP à être disponible en

Sollte es zugelassen werden, wäre Obicetrapib, lizenziert von NewAmsterdam Pharma, der erste CETP-Hemmer, der als Ergänzung zur Ernährung für Patienten

S'il est approuvé, l'obicetrapib, sous licence de NewAmsterdam Pharma, sera le premier inhibiteur de la CETP à être disponible en

Conducted under the Bharat Health 2025 initiative, the national expo will provide a platform for B2B, reverse buyer-seller meets with

NMSA president Pihoto S Rochill said the association "stands firmly against the notification" and will continue its peaceful agitation until

Highlighting the importance of education and institutions, Dr BC Bhagwan said the Malnad region needs more health-related education institutions. Chikkamagaluru

STOCKHOLM, Sept. 3, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have

Highlighting the importance of education and institutions, Dr BC Bhagwan said the Malnad region needs more health-related education institutions. Chikkamagaluru

S'il est approuvé, l'obicetrapib, sous licence de NewAmsterdam Pharma, sera le premier inhibiteur de la CETP à être disponible en

STOCKHOLM, Sept. 3, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have